These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35107425)

  • 21. HIV-1 drug resistance-associated mutations among HIV-1 infected drug-naïve antenatal clinic attendees in rural Kenya.
    Kiptoo M; Brooks J; Lihana RW; Sandstrom P; Ng'ang'a Z; Kinyua J; Lagat N; Okoth F; Songok EM
    BMC Infect Dis; 2013 Nov; 13():517. PubMed ID: 24180455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of human immunodeficiency virus Type 1 phylogenetic clusters with multidrug resistance mutations among 2011 to 2017 blood donors from the highly endemic Northern Brazilian Amazon.
    Esashika Crispim MA; da Guarda Reis MN; Fraiji N; Bello G; Stefani MMA
    Transfusion; 2019 Aug; 59(8):2593-2601. PubMed ID: 31119759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Remote Digital Psychiatry for Mobile Mental Health Assessment and Therapy: MindLogger Platform Development Study.
    Klein A; Clucas J; Krishnakumar A; Ghosh SS; Van Auken W; Thonet B; Sabram I; Acuna N; Keshavan A; Rossiter H; Xiao Y; Semenuta S; Badioli A; Konishcheva K; Abraham SA; Alexander LM; Merikangas KR; Swendsen J; Lindner AB; Milham MP
    J Med Internet Res; 2021 Nov; 23(11):e22369. PubMed ID: 34762054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medication Management Apps for Diabetes: Systematic Assessment of the Transparency and Reliability of Health Information Dissemination.
    Huang Z; Lum E; Car J
    JMIR Mhealth Uhealth; 2020 Feb; 8(2):e15364. PubMed ID: 32130163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Rise and Need for Mobile Apps for Maternal and Child Health Care in China: Survey Based on App Markets.
    Zhang P; Dong L; Chen H; Chai Y; Liu J
    JMIR Mhealth Uhealth; 2018 Jun; 6(6):e140. PubMed ID: 29884601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mobile Apps for Drug-Drug Interaction Checks in Chinese App Stores: Systematic Review and Content Analysis.
    Shen C; Jiang B; Yang Q; Wang C; Lu KZ; Gu M; Yuan J
    JMIR Mhealth Uhealth; 2021 Jun; 9(6):e26262. PubMed ID: 33962910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mobile applications in HIV self-management: A systematic review of scientific literature.
    Mehraeen E; SeyedAlinaghi S; Pashaei Z; Mirzapour P; Barzegary A; Vahedi F; Qaderi K; Tantuoyir MM; Nazeri Z; Karimi A; Mehrtak M; Heydari M
    AIDS Rev; 2022 Mar; 24(1):24-31. PubMed ID: 34723447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mobile Apps for Medication Management: Review and Analysis.
    Tabi K; Randhawa AS; Choi F; Mithani Z; Albers F; Schnieder M; Nikoo M; Vigo D; Jang K; Demlova R; Krausz M
    JMIR Mhealth Uhealth; 2019 Sep; 7(9):e13608. PubMed ID: 31512580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identifications of drug resistance mutations among antiretroviral treatment naive HIV-1 patients in Peninsular Malaysia.
    Zain RM; Ibrahim N; Ismail S; Suppiah J; Mat Rahim NA; Thayan R
    Asian Pac J Trop Med; 2017 Jan; 10(1):75-78. PubMed ID: 28107870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mobile Apps for Blood Pressure Monitoring: Systematic Search in App Stores and Content Analysis.
    Jamaladin H; van de Belt TH; Luijpers LC; de Graaff FR; Bredie SJ; Roeleveld N; van Gelder MM
    JMIR Mhealth Uhealth; 2018 Nov; 6(11):e187. PubMed ID: 30429116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. German Mobile Apps in Rheumatology: Review and Analysis Using the Mobile Application Rating Scale (MARS).
    Knitza J; Tascilar K; Messner EM; Meyer M; Vossen D; Pulla A; Bosch P; Kittler J; Kleyer A; Sewerin P; Mucke J; Haase I; Simon D; Krusche M
    JMIR Mhealth Uhealth; 2019 Aug; 7(8):e14991. PubMed ID: 31381501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of integrase inhibitors associated resistance mutations among HIV-1C isolates.
    Mulu A; Maier M; Liebert UG
    J Transl Med; 2015 Dec; 13():377. PubMed ID: 26626277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative evaluation of the ViroSeq™ HIV-1 genotyping system and an in-house method for analysis of HIV-1 drug-resistance mutations in China.
    Xu S; Zhong P; Li J; Song A; Li H; Nie J; Li X; Wang Y
    Mol Diagn Ther; 2011 Feb; 15(1):41-52. PubMed ID: 21469769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV drug resistance tendencies in Latvia.
    Kolupajeva T; Aldins P; Guseva L; Dusacka D; Sondore V; Viksna L; Rozentale B
    Cent Eur J Public Health; 2008 Sep; 16(3):138-40. PubMed ID: 18935781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving Linkage to HIV Care Through Mobile Phone Apps: Randomized Controlled Trial.
    Venter W; Coleman J; Chan VL; Shubber Z; Phatsoane M; Gorgens M; Stewart-Isherwood L; Carmona S; Fraser-Hurt N
    JMIR Mhealth Uhealth; 2018 Jul; 6(7):e155. PubMed ID: 30021706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered viral fitness and drug susceptibility in HIV-1 carrying mutations that confer resistance to nonnucleoside reverse transcriptase and integrase strand transfer inhibitors.
    Hu Z; Kuritzkes DR
    J Virol; 2014 Aug; 88(16):9268-76. PubMed ID: 24899199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug susceptibility and resistance mutations after first-line failure in resource limited settings.
    Wallis CL; Aga E; Ribaudo H; Saravanan S; Norton M; Stevens W; Kumarasamy N; Bartlett J; Katzenstein D;
    Clin Infect Dis; 2014 Sep; 59(5):706-15. PubMed ID: 24795328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends in drug resistance prevalence in HIV-1-infected children in Madrid: 1993 to 2010 analysis.
    de Mulder M; Yebra G; Navas A; Martin L; de Jose MI; Navarro ML; de Ory SJ; Gonzalez-Granado I; Mellado MJ; Ramos JT; Holguin A
    Pediatr Infect Dis J; 2012 Nov; 31(11):e213-21. PubMed ID: 22785049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Limited evolution but increasing trends of primary non-nucleoside reverse transcriptase inhibitor resistance mutations in therapy-naive HIV-1-infected individuals in India.
    Neogi U; Gupta S; Palchaudhuri R; Rao SD; Shastri S; Diwan V; Laishram RS; De Costa A; Shet A
    Antivir Ther; 2014; 19(8):813-8. PubMed ID: 24699043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug Resistance-Associated Mutations in Antiretroviral Treatment-Experienced Patients in Kuwait.
    Chehadeh W; Albaksami O; John SE; Al-Nakib W
    Med Princ Pract; 2018; 27(2):152-157. PubMed ID: 29506011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.